Johanna Rautio-Eerola

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Living Alone Is Associated with Discontinuation of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease.

Living Alone Is Associated with Discontinuation of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease.

Journal: European neurology
Published: April 14, 2025

Direct Initiation of Levodopa-Carbidopa Intestinal Gel Infusion After a Positive Levodopa Challenge Test in Advanced Parkinson's Disease.

Direct Initiation of Levodopa-Carbidopa Intestinal Gel Infusion After a Positive Levodopa Challenge Test in Advanced Parkinson's Disease.

Journal: Brain and behavior
Published: August 27, 2024

Clinical and Brain Morphometry Predictors of Deep Brain Stimulation Outcome in Parkinson's Disease.

Clinical and Brain Morphometry Predictors of Deep Brain Stimulation Outcome in Parkinson's Disease.

Journal: Brain topography
Published: December 29, 2023

Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single-Center Study of 30 Patients.

Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single-Center Study of 30 Patients.

Journal: Movement disorders clinical practice
Published: June 14, 2023

Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial.

Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 19, 2022

Real-Life Experience on Directional Deep Brain Stimulation in Patients with Advanced Parkinson's Disease.

Real-Life Experience on Directional Deep Brain Stimulation in Patients with Advanced Parkinson's Disease.

Journal: Journal of personalized medicine
Published: June 23, 2022

Single-Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa-Carbidopa Intestinal Gel.

Single-Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa-Carbidopa Intestinal Gel.

Journal: Movement disorders clinical practice
Published: May 12, 2021

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel.

Journal: Brain and behavior
Published: April 28, 2021

Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease.

Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease.

Journal: Annals of neurology
Published: January 19, 2021

Validation of the Finnish Version of the Unified Dyskinesia Rating Scale.

Validation of the Finnish Version of the Unified Dyskinesia Rating Scale.

Journal: European neurology
Published: January 06, 2021

Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.

Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.

Journal: Brain : a journal of neurology
Published: August 16, 2019

Phosphorylation of Parkin at serine 65 is essential for its activation in vivo.

Phosphorylation of Parkin at serine 65 is essential for its activation in vivo.

Journal: Open biology
Published: November 09, 2018
Showing 1-12 of 17

Last Updated: 09/26/2026